236 related articles for article (PubMed ID: 22790638)
1. [Recurrent cellulitis due to Helicobacter cinaedi after chemotherapy for malignant lymphoma].
Ishizawa J; Mori T; Tsukada Y; Matsuki E; Yokoyama K; Shimizu T; Sugita K; Murata M; Iwata S; Okamoto S
Rinsho Ketsueki; 2012 Jun; 53(6):623-7. PubMed ID: 22790638
[TBL] [Abstract][Full Text] [Related]
2. Recurrent Helicobacter cinaedi cellulitis and bacteremia in a patient with systemic lupus erythematosus.
Kikuchi H; Asako K; Tansho S; Ueda T; Koshio O; Ubagai T; Asahara M; Kawakami S; Ono Y
Intern Med; 2012; 51(22):3185-8. PubMed ID: 23154730
[TBL] [Abstract][Full Text] [Related]
3. [Repetition of Helicobacter cinaedi infections during chemotherapy for malignant lymphoma].
Ono M; Ohnishi S; Onishi R; Takahashi S; Kobayashi Y; Suzuki M; Kubo K; Dazai M; Yamamoto J; Oda H; Tada K; Takahashi T; Miyagishima T
Rinsho Ketsueki; 2010 Dec; 51(12):1781-5. PubMed ID: 21258189
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia.
Toyofuku M; Tomida J; Kawamura Y; Miyata I; Yuza Y; Horikoshi Y
J Infect Chemother; 2016 Oct; 22(10):704-6. PubMed ID: 27040158
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery.
Kitamura T; Kawamura Y; Ohkusu K; Masaki T; Iwashita H; Sawa T; Fujii S; Okamoto T; Akaike T
J Clin Microbiol; 2007 Jan; 45(1):31-8. PubMed ID: 17079500
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients.
Kiehlbauch JA; Tauxe RV; Baker CN; Wachsmuth IK
Ann Intern Med; 1994 Jul; 121(2):90-3. PubMed ID: 8017741
[TBL] [Abstract][Full Text] [Related]
7. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter cinaedi bacteremia with cellulitis after ABO-incompatible living-donor liver transplantation: Case report.
Mishima K; Obara H; Sugita K; Shinoda M; Kitago M; Abe Y; Hibi T; Yagi H; Matsubara K; Mori T; Takano Y; Fujiwara H; Itano O; Hasegawa N; Iwata S; Kitagawa Y
World J Gastroenterol; 2015 Jul; 21(25):7911-5. PubMed ID: 26167092
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia Possibly Caused by Helicobacter cinaedi and Associated with Painful Erythema in Rheumatoid Arthritis with Malignant Lymphoma.
Fujita S; Hayashi H; Kodama S; Mukai T; Morita Y
Intern Med; 2018 Dec; 57(24):3663-3666. PubMed ID: 30146580
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of Helicobacter cinaedi infection.
Shimizu S; Inokuma D; Watanabe M; Sakai T; Yamamoto S; Tsuchiya K; Shimizu H
Acta Derm Venereol; 2013 Mar; 93(2):165-7. PubMed ID: 22735294
[TBL] [Abstract][Full Text] [Related]
11. Recurrent bacteremia with Helicobacter cinaedi: case report and review of the literature.
Uçkay I; Garbino J; Dietrich PY; Ninet B; Rohner P; Jacomo V
BMC Infect Dis; 2006 May; 6():86. PubMed ID: 16719920
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
[TBL] [Abstract][Full Text] [Related]
14. [A case of recurrent Helicobacter cinaedi-associated bacteremia in a small cell lung cancer patient during chemotherapy].
Nishine H; Kasai S; Yoshikawa M; Otsuka Y; Tokuda H
Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):26-30. PubMed ID: 17313023
[TBL] [Abstract][Full Text] [Related]
15. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter cinaedi bacteremia with cellulitis in a living-donor kidney transplant recipient identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a case report.
Katsuma A; Yamamoto I; Tsuchiya Y; Kawabe M; Yamakawa T; Katsumata H; Mafune A; Nakada Y; Kobayashi A; Koike K; Shimizu A; Tanno Y; Ohkido I; Tsuboi N; Hori S; Yamamoto H; Yokoo T
BMC Res Notes; 2017 Feb; 10(1):87. PubMed ID: 28173879
[TBL] [Abstract][Full Text] [Related]
17. Phase II/III study of R-CHOP-21 versus R-CHOP-14 for untreated indolent B-cell non-Hodgkin's lymphoma: JCOG 0203 trial.
Watanabe T; Tobinai K; Shibata T; Tsukasaki K; Morishima Y; Maseki N; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Takeuchi K; Nawano S; Terauchi T; Hotta T
J Clin Oncol; 2011 Oct; 29(30):3990-8. PubMed ID: 21931035
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter cinaedi kidney cyst infection and bacteremia in a patient with autosomal dominant polycystic kidney disease.
Mandai S; Kasagi Y; Kusaka K; Shikuma S; Akita W; Kuwahara M
J Infect Chemother; 2014 Nov; 20(11):732-4. PubMed ID: 25131293
[TBL] [Abstract][Full Text] [Related]
19. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
Pei SN; Ma MC; Wang MC; Kuo CY; Rau KM; Su CY; Chen CH
Ann Hematol; 2012 Jul; 91(7):1007-12. PubMed ID: 22273839
[TBL] [Abstract][Full Text] [Related]
20. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
